VRDN Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 0.65%

Insider Buying (Last 12 Months): $40,616,302.00

Insider Selling (Last 12 Months): $0.00

Viridian Therapeutics Insider Trading History Chart

Viridian Therapeutics Share Price & Price History

^$19.03

▲ +0.3 (1.60%)

As of 12/20/2024 06:31 PM ET

Days: 30 | 90 | 365

First JFK… next Elon?

From Porter & Company | Ad

Today, I have another controversial prediction. One which I will take no pleasure in seeing come true. See, even with President Trump returning as the leader of our free country, I believe Elon Musk is in mortal danger.

I share with you in this special investigative documentary.

Viridian Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
9/27/2024	Stephen F Mahoney	CEO	Buy	21,400	$23.33	$499,262.00	21,400
9/27/2024	Thomas W Beetham	COO	Buy	5,000	$23.41	$117,050.00	6,000
9/13/2024	Fairmount Funds Management Llc	Director	Buy	1,600,000	$18.75	$30,000,000.00	3,445,813
1/22/2024	Fairmount Funds Management Llc	Director	Buy	476,190	$21.00	$9,999,990.00	1,839,954
6/15/2023	Lara Meisner	Insider	Sell	2,269	$28.02	$63,577.38	29,971
6/5/2023	Lara Meisner	Insider	Sell	499	$25.03	$12,489.97	29,971
6/2/2023	Lara Meisner	Insider	Sell	1,875	$24.21	$45,393.75	29,971
4/12/2023	Scott Dunseth Myers	CEO	Buy	4,000	$25.37	$101,480.00	259,500
3/13/2023	Scott Dunseth Myers	CEO	Buy	5,500	$29.15	$160,325.00	255,500
3/9/2023	Lara Meisner	General Counsel	Sell	29,971	$29.07	$871,256.97
2/2/2023	Jonathan Violin	Insider	Sell	50,000	$36.80	$1,840,000.00	430,905
1/23/2023	Lara Meisner	General Counsel	Sell	6,843	$35.66	$244,021.38
1/17/2023	Barrett Katz	insider	Sell	24,853	$37.21	$924,780.13
1/13/2023	Barrett Katz	insider	Sell	4,147	$37.01	$153,480.47
1/10/2023	Barrett Katz	insider	Sell	47,377	$35.30	$1,672,408.10
12/20/2022	Lara Meisner	General Counsel	Sell	600	$28.07	$16,842.00
12/16/2022	Lara Meisner	General Counsel	Sell	1,297	$28.44	$36,886.68
12/14/2022	Lara Meisner	General Counsel	Sell	15,656	$28.12	$440,246.72
12/12/2022	Lara Meisner	General Counsel	Sell	600	$28.05	$16,830.00
11/15/2022	Lara Meisner	General Counsel	Sell	8,125	$22.05	$179,156.25
8/17/2022	Fairmount Funds Management Llc	Director	Buy	425,531	$23.50	$9,999,978.50	1,363,764
6/1/2022	Jonathan Violin	Insider	Sell	30,000	$12.20	$366,000.00	480,905
5/2/2022	Jonathan Violin	CEO	Sell	30,000	$13.04	$391,200.00	510,905
4/4/2022	Jonathan Violin	Insider	Sell	3,600	$18.93	$68,148.00	540,905
4/1/2022	Jonathan Violin	Insider	Sell	26,400	$18.92	$499,488.00	540,905
2/3/2022	Jonathan Violin	Insider	Sell	909	$19.16	$17,416.44
2/1/2022	Jonathan Violin	Insider	Sell	16,751	$19.55	$327,482.05

Vladimir Lenin was right…

From Porter & Company | Ad

The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold $3 billion of Amazon… it’s why Nvidia’s CEO just sold $713 million... and it’s why Zuckerberg just sold $1.3 billion in Meta stock. The financial establishment doesn’t want you to know about this… but a controversial new documentary just pulled back the curtain and exposed what’s really going on. It’s called The Final Frontier.

Including the name of the #1 company to buy.

SEC Filings (Institutional Ownership Changes) for Viridian Therapeutics (NASDAQ:VRDN)

Institutional Buying and Selling by Quarter

Viridian Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
12/19/2024	Principal Financial Group Inc.	172,810	$3.93M	0.0%	+1,603.4%	0.218%
12/13/2024	Lord Abbett & CO. LLC	391,958	$8.92M	0.0%	N/A	0.495%
12/13/2024	Exome Asset Management LLC	174,400	$3.97M	2.7%	N/A	0.220%
11/16/2024	Geode Capital Management LLC	1,493,311	$33.98M	0.0%	+5.8%	1.885%
11/15/2024	Barclays PLC	125,397	$2.85M	0.0%	+113.1%	0.158%
11/15/2024	Y Intercept Hong Kong Ltd	29,002	$0.66M	0.0%	N/A	0.037%
11/15/2024	Wellington Management Group LLP	235,987	$5.37M	0.0%	-16.9%	0.298%
11/15/2024	Two Sigma Advisers LP	444,800	$10.12M	0.0%	-15.5%	0.562%
11/15/2024	Sphera Funds Management LTD.	86,094	$1.96M	0.3%	N/A	0.109%
11/15/2024	State Street Corp	2,379,774	$54.14M	0.0%	-14.2%	3.004%
11/15/2024	Point72 Asset Management L.P.	34,627	$0.79M	0.0%	N/A	0.044%
11/15/2024	Polar Asset Management Partners Inc.	163,000	$3.71M	0.1%	+48.3%	0.206%
11/15/2024	Parkman Healthcare Partners LLC	425,000	$9.67M	1.2%	N/A	0.537%
11/15/2024	HighVista Strategies LLC	185,240	$4.21M	1.5%	-6.7%	0.234%
11/15/2024	Cinctive Capital Management LP	26,541	$0.60M	0.0%	-43.8%	0.034%
11/15/2024	Point72 Asia Singapore Pte. Ltd.	6,543	$0.15M	0.0%	N/A	0.010%
11/14/2024	Maverick Capital Ltd.	1,997,153	$45.44M	0.9%	-39.6%	3.126%
11/14/2024	PDT Partners LLC	33,475	$0.76M	0.1%	N/A	0.052%
11/14/2024	Walleye Capital LLC	560,007	$12.74M	0.0%	+30.1%	0.877%
11/14/2024	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	89,496	$2.04M	0.0%	+29.1%	0.140%
11/14/2024	Zurcher Kantonalbank Zurich Cantonalbank	13,997	$0.32M	0.0%	+17.0%	0.022%
11/13/2024	Great Point Partners LLC	750,000	$17.06M	5.0%	+50.0%	1.174%
11/13/2024	FMR LLC	11,183,478	$254.42M	0.0%	+16.8%	17.504%
11/13/2024	The Manufacturers Life Insurance Company	24,732	$0.56M	0.0%	-21.9%	0.039%
11/13/2024	Fisher Asset Management LLC	494,924	$11.26M	0.0%	+25.1%	0.775%
11/12/2024	Algert Global LLC	114,913	$2.61M	0.1%	+107.1%	0.180%
11/12/2024	Eagle Asset Management Inc.	313,130	$7.89M	0.0%	-16.2%	0.490%
11/12/2024	Charles Schwab Investment Management Inc.	516,213	$11.74M	0.0%	+6.7%	0.808%
11/9/2024	Intech Investment Management LLC	18,566	$0.42M	0.0%	N/A	0.029%
11/8/2024	Connor Clark & Lunn Investment Management Ltd.	9,130	$0.21M	0.0%	N/A	0.014%
11/7/2024	Quest Partners LLC	1,276	$29K	0.0%	-78.9%	0.002%
11/2/2024	Mesirow Financial Investment Management Inc.	16,350	$0.37M	0.0%	N/A	0.026%
10/31/2024	Principal Financial Group Inc.	172,810	$3.93M	0.0%	+1,603.4%	0.270%
10/30/2024	AlphaCentric Advisors LLC	15,000	$0.34M	0.3%	+20.0%	0.023%
10/24/2024	Novo Holdings A S	2,385,000	$54.26M	2.7%	+19.3%	3.733%
10/23/2024	Hennion & Walsh Asset Management Inc.	197,401	$4.49M	0.2%	+10.4%	0.309%
10/22/2024	International Assets Investment Management LLC	19,997	$0.46M	0.0%	N/A	0.031%
10/3/2024	SG Americas Securities LLC	16,441	$0.37M	0.0%	-64.3%	0.026%
8/20/2024	Novo Holdings A S	2,000,000	$26.02M	1.3%	+81.8%	3.134%
8/16/2024	Perceptive Advisors LLC	1,631,828	$21.23M	0.5%	-55.4%	2.557%
8/16/2024	Algert Global LLC	55,493	$0.72M	0.0%	+46.7%	0.087%
8/15/2024	The Manufacturers Life Insurance Company	31,687	$0.41M	0.0%	+30.7%	0.050%
8/15/2024	Millennium Management LLC	228,182	$2.97M	0.0%	+1,014.7%	0.358%
8/15/2024	Maverick Capital Ltd.	3,307,945	$43.04M	0.8%	+22.9%	5.183%
8/15/2024	Affinity Asset Advisors LLC	150,000	$1.95M	0.2%	N/A	0.235%
8/14/2024	Squarepoint Ops LLC	142,936	$1.86M	0.0%	+430.3%	0.224%
8/14/2024	Great Point Partners LLC	500,000	$6.51M	1.2%	-62.5%	0.783%
8/14/2024	Marshall Wace LLP	72,974	$0.95M	0.0%	-7.3%	0.114%
8/14/2024	Profund Advisors LLC	26,990	$0.35M	0.0%	-57.2%	0.042%
8/13/2024	DCF Advisers LLC	17,750	$0.23M	0.1%	+22.4%	0.028%
8/9/2024	Renaissance Technologies LLC	247,600	$3.22M	0.0%	-5.4%	0.388%
8/9/2024	Dimensional Fund Advisors LP	107,580	$1.40M	0.0%	+968.3%	0.169%
8/6/2024	Quest Partners LLC	6,056	$79K	0.0%	+344.0%	0.009%
8/6/2024	Candriam S.C.A.	749,804	$9.75M	0.1%	+167.8%	1.175%
8/5/2024	Arizona State Retirement System	13,178	$0.17M	0.0%	+14.7%	0.021%
8/1/2024	Rhumbline Advisers	90,826	$1.18M	0.0%	+34.5%	0.142%
7/29/2024	Principal Financial Group Inc.	10,145	$0.13M	0.0%	-14.9%	0.016%
7/29/2024	Zurcher Kantonalbank Zurich Cantonalbank	11,961	$0.16M	0.0%	+24.6%	0.019%
7/26/2024	Bank of New York Mellon Corp	208,676	$2.72M	0.0%	+37.4%	0.327%
7/26/2024	AlphaCentric Advisors LLC	12,500	$0.16M	0.1%	+108.3%	0.020%
7/20/2024	Hennion & Walsh Asset Management Inc.	178,855	$2.33M	0.1%	+62.9%	0.280%
7/12/2024	SG Americas Securities LLC	46,056	$0.60M	0.0%	N/A	0.072%
6/3/2024	Kopp LeRoy C	205,640	$3.60M	2.1%	N/A	0.322%
5/16/2024	California State Teachers Retirement System	42,596	$0.75M	0.0%	+13.9%	0.067%
5/16/2024	Kynam Capital Management LP	133,877	$2.34M	0.2%	-78.0%	0.210%
5/15/2024	Yiheng Capital Management L.P.	948,130	$16.60M	0.9%	-22.8%	1.486%
5/15/2024	Bellevue Group AG	19,100	$0.33M	0.0%	-36.3%	0.030%
5/15/2024	Price T Rowe Associates Inc. MD	31,369	$0.55M	0.0%	+20.9%	0.049%
5/14/2024	American International Group Inc.	24,515	$0.43M	0.0%	+15.4%	0.038%
5/13/2024	Ameritas Investment Partners Inc.	4,961	$87K	0.0%	+19.2%	0.008%
5/10/2024	Vanguard Group Inc.	3,234,279	$56.63M	0.0%	+7.8%	5.068%
5/9/2024	State Board of Administration of Florida Retirement System	9,580	$0.17M	0.0%	-20.7%	0.015%
5/8/2024	Russell Investments Group Ltd.	321,606	$5.63M	0.0%	-2.4%	0.504%
5/7/2024	Swiss National Bank	82,900	$1.45M	0.0%	+23.4%	0.130%
5/1/2024	Mirae Asset Global Investments Co. Ltd.	28,822	$0.51M	0.0%	+4.1%	0.045%
4/29/2024	Principal Financial Group Inc.	11,915	$0.21M	0.0%	+9.7%	0.019%
4/25/2024	Rosalind Advisors Inc.	300,000	$5.25M	4.9%	-16.7%	0.478%
4/17/2024	Hennion & Walsh Asset Management Inc.	109,820	$1.92M	0.1%	+44.9%	0.175%
3/5/2024	Wellington Management Group LLP	192,097	$4.18M	0.0%	-10.9%	0.306%
2/26/2024	Virtu Financial LLC	19,456	$0.42M	0.0%	N/A	0.037%
2/26/2024	Perceptive Advisors LLC	1,730,212	$37.68M	0.8%	+71.1%	3.290%
2/15/2024	Octagon Capital Advisors LP	620,000	$13.50M	2.2%	-41.9%	1.179%
2/14/2024	Commodore Capital LP	1,924,074	$41.91M	3.7%	-12.5%	3.659%
2/14/2024	Braidwell LP	323,102	$7.04M	0.3%	-81.4%	0.614%
2/14/2024	Bellevue Group AG	30,000	$0.65M	0.0%	-53.0%	0.057%
2/14/2024	Kynam Capital Management LP	607,915	$13.24M	1.5%	-13.1%	1.156%
2/14/2024	Vestal Point Capital LP	1,000,000	$21.78M	2.3%	N/A	1.902%
2/14/2024	RTW Investments LP	605,816	$13.20M	0.2%	N/A	1.152%
2/13/2024	Tower Research Capital LLC TRC	2,331	$51K	0.0%	-74.5%	0.004%
2/13/2024	DCF Advisers LLC	9,500	$0.21M	0.1%	-29.6%	0.018%
2/13/2024	Affinity Asset Advisors LLC	50,000	$1.09M	0.2%	N/A	0.095%
2/13/2024	Rafferty Asset Management LLC	202,491	$4.41M	0.0%	-22.8%	0.385%
2/12/2024	Eagle Asset Management Inc.	453,308	$9.87M	0.1%	-1.3%	0.862%
2/7/2024	E Fund Management Co. Ltd.	10,875	$0.24M	0.0%	-19.1%	0.021%
2/6/2024	Charles Schwab Investment Management Inc.	371,311	$8.09M	0.0%	+18.5%	0.706%
2/6/2024	Swiss National Bank	67,200	$1.46M	0.0%	+1.2%	0.128%
2/5/2024	Russell Investments Group Ltd.	329,484	$7.18M	0.0%	+10.1%	0.627%
2/1/2024	New York State Common Retirement Fund	17,495	$0.38M	0.0%	+9.7%	0.033%
1/31/2024	Knights of Columbus Asset Advisors LLC	153,949	$3.35M	0.2%	+420.9%	0.293%
1/30/2024	Zurcher Kantonalbank Zurich Cantonalbank	8,369	$0.18M	0.0%	+122.6%	0.016%

Data available starting January 2016

Viridian Therapeutics, Inc., a biotechnology company, discover and develops treatments for serious and rare diseases. The company's product pipeline includes VRDN-001, a monoclonal antibody targeting insulin-like growth factor-1 receptor that is in Phase 3 clinical trial for the treatment of thyroid eye disease (TED); and VRDN-003, a next generation IGF-1R humanized monoclonal antibodies targeting IGF-1R and incorporating half-life extension technology for the treatment of TED. It also provides VRDN-006 a preclinical program for autoimmune disease. In addition, the company offers VRDN-006 and VRDN-008 a preclinical program for autoimmune disease. The company was formerly known as Miragen Therapeutics, Inc. and changed its name to Viridian Therapeutics, Inc. in January 2021.Viridian Therapeutics, Inc. was founded in 2010 and is headquartered in Waltham, Massachusetts.

Today's Range

Now: $19.03

$18.19

$19.45

50 Day Range

MA: $21.72

$17.85

$25.71

52 Week Range

Now: $19.03

$11.40

$27.20

Volume

4,979,240 shs

Average Volume

1,173,159 shs

Market Capitalization

$1.51 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.04

Who are the company insiders with the largest holdings of Viridian Therapeutics?: Viridian Therapeutics' top insider investors include:
Fairmount Funds Management Llc (Director)
Jonathan Violin (Insider)
Scott Dunseth Myers (CEO)
Lara Meisner (Insider)
Stephen F Mahoney (CEO)
Thomas W Beetham (COO)
Barrett Katz (Insider)
Lara Meisner (General Counsel)
Learn More about top insider investors at Viridian Therapeutics.
Who are the major institutional investors of Viridian Therapeutics?: Viridian Therapeutics' top institutional shareholders include:
FMR LLC — 17.50%
Novo Holdings A S — 3.73%
State Street Corp — 3.00%
Maverick Capital Ltd. — 3.13%
Geode Capital Management LLC — 1.89%
Great Point Partners LLC — 1.17%
Learn More about top institutional investors of Viridian Therapeutics stock.
Which major investors are selling Viridian Therapeutics stock?: During the last quarter, VRDN stock was sold by these institutional investors:
Maverick Capital Ltd.
State Street Corp
Two Sigma Advisers LP
Eagle Asset Management Inc.
Wellington Management Group LLP
Belvedere Trading LLC
SG Americas Securities LLC
Cinctive Capital Management LP
Which major investors are buying Viridian Therapeutics stock?: Within the previous quarter, VRDN stock was acquired by institutional investors including:
FMR LLC
Parkman Healthcare Partners LLC
Lord Abbett & CO. LLC
Novo Holdings A S
Great Point Partners LLC
Exome Asset Management LLC
Principal Financial Group Inc.
Principal Financial Group Inc.
In the previous year, these company insiders have bought Viridian Therapeutics stock:
Fairmount Funds Management Llc (Director)
Jonathan Violin (Insider)
Scott Dunseth Myers (CEO)
Lara Meisner (Insider)
Learn More investors buying Viridian Therapeutics stock.

From Behind the Markets | Ad

My research indicates there is only one investment that can meet AI's unprecedented demand for energy.

Click to get the name and ticker symbol